Lymphocytic Neoplasm — Trials

Lymphocytic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

12,949 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 551–600 of 2,423 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03309878	Mogamulizumab and Pembrolizumab in Treating Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma	completed	Phase 1 / Phase 2	8	National Cancer Institute (NCI)NIH	1	Sep 21, 2023	clinicaltrials
NCT04091490	Combination of Nivolumab and DHAP in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (Nivo-DHAP)(Nivo-DHAP)	completed	Phase 2	40	State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia